All In Biotech

Drug Trial Radar · NCT05553366

Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

Last checked: Nov 20, 2026Latest source record: Aug 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,075 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,075

Actual

Start

Oct 3, 2022

Primary completion

Dec 15, 2023

Study completion Dec 15, 2023

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Sep 23, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of suzetrigine for acute pain after a bunionectomy.

Conditions

  • Acute Pain

Interventions

  • SUZDrug

    Tablets for oral administration.

  • HB/APAPDrug

    Capsules for oral administration.

  • Placebo (matched to SUZ)Drug

    Placebo matched to SUZ for oral administration.

  • Placebo (matched to HB/APAP)Drug

    Placebo matched to HB/APAP for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time-weighted Sum of the Pain Intensity Difference (SPID) as Recorded on a Numeric Pain Rating Scale (NPRS) From 0 to 48 Hours (SPID48), SUZ Compared to PlaceboTime frame: 0 to 48 hours After First Dose of Study Drug

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Shoals Medical Trials Inc.

    Sheffield, Alabama

  • Arizona Research Center

    Phoenix, Arizona

  • Woodland International Research Group

    Little Rock, Arkansas

  • Anaheim Clinical Trials

    Anaheim, California

  • Trovare Clinical Research

    Bakersfield, California

  • Pacific Research Network Inc

    San Diego, California

  • New Hope Research Development

    Tarzana, California

  • New Hope Research Development

    West Covina, California

  • Clinical Pharmacology of Miami

    Hialeah, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Kansas Spine and Specialty Hospital

    Wichita, Kansas

  • Midwest Clinical Research Center

    Dayton, Ohio

  • Center for Orthopaedic Reconstruction and Excellence

    Jenks, Oklahoma

  • HD Research LLC | First Surgical Hospital

    Bellaire, Texas

  • HD Research LLC | Legent Orthopedic Hospital

    Carrollton, Texas

  • HD Research LLC | Houston Heights Hospital

    Houston, Texas

  • Futuro Clinical Trials

    McAllen, Texas

  • Endeavor Clinical Trials

    San Antonio, Texas

  • Houston Physicians Hospital

    Webster, Texas

  • JBR Clinical Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.